These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 26250894

  • 1. Changes in the expression of collapsin response mediator protein-2 during synaptic plasticity in the mouse hippocampus.
    Kadoyama K, Matsuura K, Nakamura-Hirota T, Takano M, Otani M, Matsuyama S.
    J Neurosci Res; 2015 Nov; 93(11):1684-92. PubMed ID: 26250894
    [Abstract] [Full Text] [Related]

  • 2. Synaptotagmin1 synthesis induced by synaptic plasticity in mouse hippocampus through activation of nicotinic acetylcholine receptors.
    Nishimoto T, Kadoyama K, Taniguchi T, Takano M, Otani M, Nakamura-Hirota T, Lu Y, Matsumoto A, Matsuyama S.
    Neurosci Lett; 2011 Feb 01; 489(1):25-9. PubMed ID: 21129439
    [Abstract] [Full Text] [Related]

  • 3. The expression changes of EphA3 receptor during synaptic plasticity in mouse hippocampus through activation of nicotinic acetylcholine receptor.
    Nakamura-Hirota T, Kadoyama K, Takano M, Otani M, Matsuyama S.
    Neuroreport; 2012 Sep 12; 23(13):746-51. PubMed ID: 22811059
    [Abstract] [Full Text] [Related]

  • 4. Amyloid-β₂₅₋₃₅ induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2.
    Isono T, Yamashita N, Obara M, Araki T, Nakamura F, Kamiya Y, Alkam T, Nitta A, Nabeshima T, Mikoshiba K, Ohshima T, Goshima Y.
    Neurosci Res; 2013 Nov 12; 77(3):180-5. PubMed ID: 23994236
    [Abstract] [Full Text] [Related]

  • 5. Changes in the expression of prefoldin subunit 5 depending on synaptic plasticity in the mouse hippocampus.
    Kadoyama K, Matsuura K, Takano M, Maekura K, Inoue Y, Matsuyama S.
    Neurosci Lett; 2019 Nov 01; 712():134484. PubMed ID: 31505240
    [Abstract] [Full Text] [Related]

  • 6. Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models.
    Ikezu S, Ingraham Dixie KL, Koro L, Watanabe T, Kaibuchi K, Ikezu T.
    Acta Neuropathol Commun; 2020 Feb 04; 8(1):12. PubMed ID: 32019603
    [Abstract] [Full Text] [Related]

  • 7. Collapsin response mediator protein 2 is involved in regulating breast cancer progression.
    Shimada K, Ishikawa T, Nakamura F, Shimizu D, Chishima T, Ichikawa Y, Sasaki T, Endo I, Nagashima Y, Goshima Y.
    Breast Cancer; 2014 Nov 04; 21(6):715-23. PubMed ID: 23381229
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phosphorylation of CRMP2 by Cdk5 Regulates Dendritic Spine Development of Cortical Neuron in the Mouse Hippocampus.
    Jin X, Sasamoto K, Nagai J, Yamazaki Y, Saito K, Goshima Y, Inoue T, Ohshima T.
    Neural Plast; 2016 Nov 04; 2016():6790743. PubMed ID: 26819770
    [Abstract] [Full Text] [Related]

  • 13. Increased phosphorylation of collapsin response mediator protein-2 at Thr514 correlates with β-amyloid burden and synaptic deficits in Lewy body dementias.
    Xing H, Lim YA, Chong JR, Lee JH, Aarsland D, Ballard CG, Francis PT, Chen CP, Lai MK.
    Mol Brain; 2016 Sep 08; 9(1):84. PubMed ID: 27609071
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nicotine induces dendritic spine remodeling in cultured hippocampal neurons.
    Oda A, Yamagata K, Nakagomi S, Uejima H, Wiriyasermkul P, Ohgaki R, Nagamori S, Kanai Y, Tanaka H.
    J Neurochem; 2014 Jan 08; 128(2):246-55. PubMed ID: 24117996
    [Abstract] [Full Text] [Related]

  • 16. CaMKII phosphorylates collapsin response mediator protein 2 and modulates axonal damage during glutamate excitotoxicity.
    Hou ST, Jiang SX, Aylsworth A, Ferguson G, Slinn J, Hu H, Leung T, Kappler J, Kaibuchi K.
    J Neurochem; 2009 Nov 08; 111(3):870-81. PubMed ID: 19735446
    [Abstract] [Full Text] [Related]

  • 17. Co-localization of hippocampal cholinergic neurostimulating peptide precursor with collapsin response mediator protein-2 at presynaptic terminals in hippocampus.
    Kato D, Mitake S, Mizuno M, Kanamori T, Suzuki T, Ojika K, Matsukawa N.
    Neurosci Lett; 2012 May 31; 517(2):92-7. PubMed ID: 22542739
    [Abstract] [Full Text] [Related]

  • 18. Disruption of the psychiatric risk gene Ankyrin 3 enhances microtubule dynamics through GSK3/CRMP2 signaling.
    Garza JC, Qi X, Gjeluci K, Leussis MP, Basu H, Reis SA, Zhao WN, Piguel NH, Penzes P, Haggarty SJ, Martens GJ, Poelmans G, Petryshen TL.
    Transl Psychiatry; 2018 Jul 25; 8(1):135. PubMed ID: 30046097
    [Abstract] [Full Text] [Related]

  • 19. (S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5.
    Moutal A, François-Moutal L, Perez-Miller S, Cottier K, Chew LA, Yeon SK, Dai J, Park KD, Khanna M, Khanna R.
    Mol Neurobiol; 2016 Apr 25; 53(3):1959-1976. PubMed ID: 25846820
    [Abstract] [Full Text] [Related]

  • 20. Long term alterations in synaptic physiology, expression of β2 nicotinic receptors and ERK1/2 signaling in the hippocampus of rats with prenatal nicotine exposure.
    Parameshwaran K, Buabeid MA, Bhattacharya S, Uthayathas S, Kariharan T, Dhanasekaran M, Suppiramaniam V.
    Neurobiol Learn Mem; 2013 Nov 25; 106():102-11. PubMed ID: 23871741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.